Nxera Pharma Co Eulerpool Ziņas

Nxera Pharma Co Akciju Ziņas

Nxera Pharma Co tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Nxera Pharma Co ziņas mēs apkopojam šeit.

• 20. decembris ·

  Yahoo
  Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 19. decembris ·

  Yahoo
  Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia
• 5. novembris ·

  Yahoo
  Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
• 1. novembris ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024
• 23. oktobris ·

  Yahoo
  Nxera Pharma Wins Biotech Company of the Year and Financing Deal of the Year at the Citeline Japan Awards 2024
• 18. oktobris ·

  Yahoo
  Nxera Pharma to Host R&D Day 2024
• 1. oktobris ·

  Yahoo
  Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan
• 1. oktobris ·

  Yahoo
  Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan
• 24. septembris ·

  Yahoo
  Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
• 13. septembris ·

  Yahoo
  Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO